40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 R...
40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial
About this item
Full title
Author / Creator
Temesgem, Zelalem , Burger, Charles , Baker, Jason , Polk, Christopher , Libertin, Claudia R , Kelley, Colleen F , Marconi, Vincent , Orenstein, Robert , Catterson, Victoria , Aronstein, William , Durrant, Cameron , Chappell, Dale , Ahmed, Omar , Chappell, Gabrielle , Badley, Andrew and for the LIVE-AIR Study Group
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Alternative Titles
Full title
40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8643764
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8643764
Other Identifiers
ISSN
2328-8957
E-ISSN
2328-8957
DOI
10.1093/ofid/ofab466.040
